William D Figg (William Figg)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

Pain Management

Transcription Factor

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

D Max Smith, William D Figg
Evidence Regarding Pharmacogenetics in Pain Management and Cancer. The oncologist 28 (3) (2023)
D Max Smith, William D Figg
Evidence Regarding Pharmacogenetics in Pain Management and Cancer. The oncologist (2023)
Michelle Monje, Tabitha Cooney, John W Glod, Jie Huang, Cody J Peer, Damien Faury, Patricia Baxter, Kim Kramer, Alicia Lenzen, Nathan J Robison, Lindsay Kilburn, Anna Vinitsky, William D Figg, Nada Jabado, Maryam Fouladi, Jason R Fangusaro, Arzu Onar-Thomas, Ira J Dunkel, Katherine E Warren
A Phase I Trial of Panobinostat in Children with Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium (PBTC-047). Neuro-oncology (2023)
William D Figg, Giorgia Fiorini, Rasheduzzaman Chowdhury, Yu Nakashima, Anthony Tumber, Michael A McDonough, Christopher J Schofield
Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2. Proteins (2023)
William D Figg, Michael A McDonough, Rasheduzzaman Chowdhury, Yu Nakashima, Zhihong Zhang, James P Holt-Martyn, Alen Krajnc, Christopher J Schofield
Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat. ChemMedChem 16 (13) (2021)
James P Holt-Martyn, Anthony Tumber, Mohammed Z Rahman, Kerstin Lippl, William D Figg, Michael A McDonough, Rasheduzzaman Chowdhury, Christopher J Schofield
Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitors. MedChemComm 10 (4) (2019)
Matthew E Cockman, Kerstin Lippl, Ya-Min Tian, Hamish B Pegg, William D Figg, Martine I Abboud, Raphael Heilig, Roman Fischer, Johanna Myllyharju, Christopher J Schofield, Peter J Ratcliffe
Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates. eLife 8 (2019)
Cody J Peer, Oliver M Hall, Tristan M Sissung, Richard Piekarz, Sanjeeve Balasubramaniam, Susan E Bates, William D Figg
A population pharmacokinetic/toxicity model for the reduction of platelets during a 48-h continuous intravenous infusion of the histone deacetylase inhibitor belinostat. Cancer chemotherapy and pharmacology 82 (3) (2018)